Drug-Induced Delirium: Diagnosis and Treatment

CNS Drugs

Volumn 5, Issue 2, 1996, Pages 103-114

  Francis Jr , Joseph ^a  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANALGESIC AGENT; ANTIPARKINSON AGENT; CHOLINERGIC RECEPTOR BLOCKING AGENT; HISTAMINE H2 RECEPTOR ANTAGONIST; HYPNOTIC AGENT; UNINDEXED DRUG;

COGNITION; CONSCIOUSNESS; DELIRIUM; DRUG MECHANISM; HUMAN; PERCEPTION; PRIORITY JOURNAL; REVIEW; RISK FACTOR;

EID: 0030026974     PISSN: 11727047     EISSN: None     Source Type: Journal    
DOI: 10.2165/00023210-199605020-00003     Document Type: Article

References (63)

1. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th ed. Washington, DC: American Psychiatric Association, 1994
2. Liptzin B, Levkoff SE, Gottlieb GL, et al. Background papers for DSM-IV: delirium. J Neuropsychiatry Clin Neurosci 1993; 5: 154-60
3. Levkoff SE, Evans DA, Liptzin B, et al. Delirium: the occurrence and persistence of symptoms among elderly hospitalized patients. Arch Intern Med 1992; 152: 334-40
4. Francis J, Martin D, Kapoor WN. A prospective study of delirium in hospitalized elderly. JAMA 1990; 263: 1097-101
5. Francis J. Delirium in older patients. J Am Geriatr Soc 1992; 40: 829-38
6. Cole MG, Primeau FJ. Prognosis of delirium in elderly hospital patients. Can Med Assoc J 1993; 149: 41-6
7. Levkoff SE, Liptzin B, Evans DA, et al. Progression and resolution of delirium in elderly patients hospitalized for acute care. Am J Geriatr Psychiatry 1994; 2: 230-8
8. Francis J, Kapoor WN. Prognosis after hospital discharge of older medical patients with delirium. J Am Geriatr Soc 1992; 40: 601-6
9. Murray AM, Levkoff SE, Wetle TT, et al. Acute delirium and functional decline in the hospitalized elderly patient. J Gerontol 1993; 48: 181-6
10. Fries BE, Mehr DR, Schneider D, et al. Mental dysfunction and resource use in nursing homes. Med Care 1993; 31: 898-920
11. Gustafson Y, Berggren D, Brannstrom B, et al. Acute confusional states in elderly patients treated for femoral neck fracture. J Am Geriatr Soc 1988; 36: 525-30
12. Marcantonio ER, Goldman L, Mangione CM, et al. A clinical prediction rule for delirium after elective noncardiac surgery. JAMA 1994; 271: 134-9
13. Dyer CB, Ashton CM, Teasdale TA. Postoperative delirium: a review of 80 primary data-collection studies. Arch Intern Med 1995; 155: 461-5
14. Trzepacz PT, Francis J. Low serum albumin and risk of delirium [letter]. Am J Psychiatry 1990; 147: 675
15. Inouye SK. The dilemma of delirium: clinical and research controversies regarding diagnosis and evaluation of delirium in hospitalized elderly medical patients. Am J Med 1994; 97: 278-88
16. Pompei P, Foreman M, Cassel CK, et al. Detecting delirium among hospitalized older patients. Arch Intern Med 1995; 155: 301-7
17. Eisemnan DP, McKegney FP. Delirium at therapeutic serum concentrations of digoxin and quinidine. Psychosomatics 1994; 35: 91-3
18. Brown AS, Rosen J. Lithium-induced delirium with therapeutic serum lithium levels: a case report. J Geriatr Psychiatry Neurol 1992; 5: 53-5
19. Sunderland T, Tariot PN, Cohen RM, et al. Anticholinergic sensitivity in patients with dementia of the Alzheimer type and age-matched controls. Arch Gen Psychiatry 1987; 44: 418-26
20. Larson EB, Kukull WA, Buchner D, et al. Adverse drug reactions associated with global cognitive impairment in elderly persons. Ann Intern Med 1987; 107: 169-73
21. Tune LE, Bylsma FW. Benzodiazepine-induced and anticholinergic-induced delirium in the elderly. Int Psychogeriatr 1991; 3: 397-408
22. Mach JR, Dysken MW, Kuskowski M, et al. Serum anticholinergic activity in hospitalized older persons with delirium: a preliminary study. J Am Geriatr Soc 1995; 43: 491-5
23. Tune L, Carr S, Hoag E, et al. Anticholinergic effects of drugs commonly prescribed for the elderly: potential means for assessing risk of delirium. Am J Psychiatry 1992; 149: 1393-4
24. Krueger JM, Walter J, Dinarello CA, et al. Sleep-promoting effects of endogenous pyrogen (interleukin-1). Am J Physiol 1984; 246: R994-9
25. Denicoff KD, Rubinow DR, Papa MZ, et al. The neuropsychiatric effects of treatment with interleukin-2 and lymphokine-activated killer cells. Ann Intern Med 1987; 107: 293-300
26. Caraceni A, Martini C, Belli F, et al. Neuropsychological and neurophysiological assessment of the central effects of interleukin-2 administration. Eur J Cancer 1993; 29: 1266-9
27. Renault PF, Hoofnagle JH, Park Y, et al. Psychiatric complications of long-term interferon alpha therapy. Arch Intern Med 1987; 147: 1577-80
28. Bolton CF, Young GB, Zochodne DW. The neurological complications of sepsis. Ann Neurol 1993; 33: 94-100
29. Stefano GB, Bilfinger TB, Fricchione GL. The immune-neurolink and the macrophage: postcardiotomy delirium, HIV-associated dementia, and psychiatry. Prog Neurobiol 1994; 42: 475-88
30. Drugs that cause psychiatric symptoms. Med Lett 1993; 35: 65-70
31. Lipowski ZJ. Delirium: acute confusional states. New York: Oxford University Press, 1990
32. American Hospital Formulary Service. Drug information. Bethesda (MD): American Society of Hospital Pharmacists, 1995
33. Kramer MS, Leventhal JM, Hutchinson TA, et al. An algorithm for the operational assessment of adverse drug reactions. I. Background, description, and instructions for use. JAMA 1979; 242: 623-32
34. Patten SB, Love EJ. Neuropsychiatric adverse drug reactions: passive reports to Health and Welfare Canada's adverse drug reaction database (1965-present). Int J Psychiatr Med 1994; 24: 45-62
35. Peters NL. Snipping the thread of life: antimuscarinic side effects of medications in the elderly. Arch Intern Med 1989; 149: 2414-20
36. Marcantonio ER, Juarez G, Goldman L, et al. The relationship of postoperative delirium with psychoactive medications. JAMA 1994; 272: 1518-22
37. Tune L, Coyle JT. Acute extrapyramidal side effects: serum levels of neuroleptics and anticholinergics. Psychopharmacology 1981; 75: 9-15
38. Baldessarini RJ, Gelenberg AJ. Using physostigmine safely. Am J Psychiatry 1979; 136: 1608-9
39. Pentel P, Peterson CD. Asystole complicating physostigmine treatment of tricyclic antidepressant overdose. Ann Emerg Med 1980; 9: 588-90
40. Rummans TA, Davis LJ, Morse RM, et al. Learning and memory impairment in older, detoxified benzodiazepine-dependent patients. Mayo Clin Proc 1993; 68: 731-7
41. Foy A, O'Connell D, Henry D, et al. Benzodiazepine use as a cause of cognitive impairment in elderly hospital inpatients. J Gerontol 1995; 50: 99-106
42. Levy AB. Delirium and seizures due to abrupt alprazolam withdrawal: case report. J Clin Psychiatry 1984; 45: 38-9
43. Foy A, Drinkwater V, March S, et al. Confusion after admission to hospital in elderly patients using benzodiazepines. BMJ 1986; 293: 1072
44. Bailey RB, Jones SR. Chronic salicylate intoxication: a common cause of morbidity in the elderly. J Am Geriatr Soc 1989; 37: 556-61
45. Iobst WF, Bridges CR, Regan-Smith MG. Antirheumatic agents: CNS toxicity and its avoidance. Geriatrics 1989 Apr: 44: 95-102
46. Goodwin JS, Regan M. Cognitive dysfunction associated with naproxen and ibuprofen in the elderly. Arthritis Rheum 1982; 25: 1013-5
47. Clark DW, Ghose K. Neuropsychiatric reactions to nonsteroidal anti-inflammatory drugs (NSAIDs): the New Zealand experience. Drug Saf 1992; 7: 460-5
48. Cantu TG, Korek JS. Central nervous system reactions to histamine-2 receptor blockers. Ann Intern Med 1991; 114: 1027-34
49. Cerra FB, Schentag JJ, McMillen M, et al. Mental status, the intensive care unit, and cimetidine. Ann Surg 1982; 196: 565-70
50. Cummings JL. Behavioral complications of drug treatment of Parkinson's disease. J Am Geriatr Soc 1991; 39: 708-16
51. Saint-Cyr JA, Taylor AE, Lang AE. Neuropsychological and psychiatric side effects in the treatment of Parkinson's disease. Neurology 1993; 43 Suppl. 6: 47-52
52. Rubey JM, Treves TA, Neufeld MY, et al. Low-dose clozapine in the treatment of levodopa-induced mental disturbances in Parkinson's disease. Neurology 1995; 45: 432-4
53. Cuetter AC, Ferrans VJ. Neurological complications of cardiovascular therapy. Curr Probl Cardiol 1987; 12: 159-211
54. Dimsdale J, Newton R, Joist T. Neuropsychological side effects of beta blockers. Arch Intern Med 1989; 149: 514-25
55. Snavely SR, Hodges GR. The neurotoxicity of antibacterial agents. Ann Intern Med 1984; 101: 92-104
56. McCue JD, Zandt JR. Acute psychoses associated with the use of ciprofloxacin and trimethoprim-sulfamethoxazole. Am J Med 1991; 90: 528-9
57. McDermott JL, Gideonse N, Campbell JW. Acute delirium associated with ciprofloxacin administration in a hospitalized elderly patient. J Am Geriatr Soc 1991; 39: 909-10
58. Meador KJ. Cognitive side effects of antiepileptic drugs. Can J Neurol Sci 1994; 21: 512-6
59. Ling MHM, Perry PJ, Tsuang MT. Side effects of corticosteroid therapy: psychiatric aspects. Arch Gen Psychiatry 1981; 38: 471-7
60. Lacomis D, Samuels MA. Adverse neurologic effects of glucocorticosteroids. J Gen Intern Med 1991; 6: 367-76
61. Hall RCW, Popkin MK, Stickney SK, et al. Presentation of the steroid psychoses. J Nerv Ment Dis 1979; 167: 229-36
62. Benbadis SR, Sila CA, Cristea RL. Mental status changes and stroke. J Gen Intern Med 1944; 9: 485-7
63. Warshaw G, Tanzer F. The effectiveness of lumbar puncture in the evaluation of delirium and fever in the hospitalized elderly. Arch Fam Med 1993; 2: 293-7